✦ LIBER ✦

Ribozymes enter clinical trials for HIV-1 treatment

✍ Scribed by Paul M Rowe

Book ID: 118552819
Publisher: The Lancet
Year: 1996
Tongue: English
Weight: 14 KB
Volume: 348
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(05)65767-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New treatment for inflammatory bowel dis

New treatment for inflammatory bowel disease could soon enter clinical trials

✍ Jane Bradbur 📂 Article 📅 2002 🏛 The Lancet 🌐 English ⚖ 59 KB

Killed HIV treatment in clinical trials

✍ Ezzell, Carol 📂 Article 📅 1988 🏛 Nature Publishing Group 🌐 English ⚖ 124 KB

Surrogacy in HIV-1 clinical trials

✍ Anton Pozniak 📂 Article 📅 1998 🏛 The Lancet 🌐 English ⚖ 49 KB

ACTG (AIDS Clinical Trials Group) 384: A

ACTG (AIDS Clinical Trials Group) 384: A Strategy Trial Comparing Consecutive Treatments for HIV-1

✍ Laura M Smeaton; Victor DeGruttola; Gregory K Robbins; Robert W Shafer 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 153 KB

HIV-1 vaccine clinical trials: the Brazi

HIV-1 vaccine clinical trials: the Brazilian experience

✍ Jonatan Ersching; Aguinaldo R. Pinto 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 161 KB

## Abstract Although the development of an effective HIV‐1 vaccine has proved very challenging for more than two decades, it remains the best hope to control the HIV pandemic. Since Brazil has particular epidemiological features, as well as adequate policies and infrastructure, the country has been

Analysis of HIV-1 clinical trials: stati

Analysis of HIV-1 clinical trials: statistical magic?

📂 Article 📅 1999 🏛 The Lancet 🌐 English ⚖ 77 KB